StockData

Family Office of America, Inc. (FOFA) stock

FOFAOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$0.90+0.00 (0.00%)

Close on Oct 19, 2026Market cap $27.44MP/E –Yield –

Family Office of America r&d expenses

Research and development expenses are spending on new products and technology.

Family Office of America's R&D Expenses for the twelve months ending Dec 31, 2023 was $1.50K, down 98.0% year over year. For fiscal 2023 it was $1.50K, down 98.0% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Dec 31, 2023$1.50K-98.0%
FY2022Dec 31, 2022$76.36K-84.7%
FY2021Dec 31, 2021$500.57K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$1.50K-98.8%
Q4 FY2022Dec 31, 2022$23.10K-81.1%
Q2 FY2022Jun 30, 2022$45.42K-64.6%
Q1 FY2022Mar 31, 2022$12.17K–
Q4 FY2021Dec 31, 2021$124.73K–
Q3 FY2021Sep 30, 2021$121.93K–
Q2 FY2021Jun 30, 2021$128.48K–

More Family Office of America figures

See a number that looks wrong?